alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 12

                                      KENTUCKY UTILITIES COMPANY

                           COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES


<TABLE>
<CAPTION>

      Year Ended December 31,            1997       1996        1995       1994        1993
                                                                (in thousands except ratios)

      Earnings
<S>                                 <C>        <C>         <C>        <C>         <C>
        Net Income                  $  85,713  $  86,163   $  76,842  $  77,512   $  81,286
      Adjustments
        Fixed charges                  39,729     39,688      40,116     34,558      32,899
        Income taxes
        Current Federal                39,353     35,656      23,597     37,058      35,893
        Current State                   8,964      7,387       5,134      8,812       9,484
        Deferred Federal--Net           1,996      5,510      12,165     (1,114)      2,837
        Deferred State--Net             1,377      2,899       3,845         13          71
        Deferred investment
          tax credit--Net                   -          -         (71)       (86)       (107)
        Income taxes included
          in Other Income
          and Deductions
        Current Fed and State          (1,099)     4,426       1,044      1,881      (2,616)
        Deferred Fed and State          1,233     (4,659)       (508)      (458)      2,817
        Amortization of
          investment credit            (4,036)    (4,013)     (4,024)    (4,024)     (4,024)
        Undistributed income of
          Electric Energy, Inc.           (37)        24          99        (39)        (38)


          Total Earnings            $ 173,193  $ 173,081   $ 158,239  $ 154,113   $ 158,502

      Fixed Charges
        Int. on long-term debt      $  37,405  $  37,584   $  36,095  $  32,147   $  31,650
        Other interest charges          2,324      2,104       4,021      2,411       1,249

          Total Fixed Charges       $  39,729  $  39,688   $  40,116  $  34,558   $  32,899


      Ratio of Earnings
        to Fixed Charges                 4.36       4.36        3.94       4.46        4.82


</TABLE>


      ____________

     Note--Rentals are not material and have not been included in fixed charges.





                                                 -60-
##### 



EXHIBIT 31.1
 CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13a-14(a) OF THE
SECURITIES EXCHANGE ACT OF 1934, AS AMENDED, AS ADOPTED PURSUANT TO SECTION 302 OF THE
SARBANES-OXLEY ACT OF 2002
  1.
    
    I have reviewed this quarterly report on Form 10-Q of Delta Apparel, Inc.;2.
    
    Based on my knowledge, this report does not contain any untrue statement of a material
fact or omit to state a material fact necessary to make the statements made, in light of
the circumstances under which such statements were made, not misleading with respect to the
period covered by this report;3.
    
    Based on my knowledge, the financial statements, and other financial information
included in this report, fairly present in all material respects the financial condition,
results of operations and cash flows of the registrant as of, and for, the periods
presented in this report;4.
    
    The registrants other certifying officer(s) and I are responsible for establishing and
maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)
and 15d-15(e)) for the registrant and have:a)
    
    Designed such disclosure controls and procedures, or caused such disclosure controls
and procedures to be designed under our supervision, to ensure that material information
relating to the registrant, including its consolidated subsidiaries, is made known to us by
others within those entities, particularly during the period in which this report is being
prepared;b)
    
    Evaluated the effectiveness of the registrants disclosure controls and procedures and
presented in this report our conclusions about the effectiveness of the disclosure controls
and procedures, as of the end of the period covered by this report based on such
evaluation; andc)
    
    Disclosed in this report any change in the registrants internal control over financial
reporting that occurred during the registrants most recent fiscal quarter (the
registrants fourth fiscal quarter in the case of an annual report) that has materially
affected, or is reasonably likely to materially affect, the registrants internal control
over financial reporting; and5.
    
    The registrants other certifying officer(s) and I have disclosed, based on our most
recent evaluation of internal control over financial reporting, to the registrants
auditors and the audit committee of registrants board of directors (or persons performing
the equivalent functions):a)
    
    All significant deficiencies and material weaknesses in the design or operation of
internal control over financial reporting which are reasonably likely to adversely affect
the registrants ability to record, process, summarize and report financial information;
andb)
    
    Any fraud, whether or not material, that involves management or other employees who
have a significant role in the registrants internal control over financial reporting.
 Date: May 12, 2006
    
    /s/ Robert W. Humphreys

President and Chief Executive Officer
 26
# 2021 FEVS SEC Summary

# 2021 Demographic Summary

# 2021 SEC Heatmap

# Current Year Raw Data

# Agency Specific Items

# Demographics

# Work-Life Programs

# image1.png
§ 345.41 Performance appraisal for inmate workers. Work supervisors should complete a performance appraisal form for each inmate semi-annually, by March 31 and September 30, or upon termination or transfer from the industrial work assignment. Copies shall be sent to the unit team. Inmate workers should discuss their appraisals with their supervisors at a mutually agreeable time in order to improve their performance. Satisfactory and unsatisfactory performance ratings shall be based on the standards in § 345.40(a). ( a ) The SOI is to ensure that evaluations are done and are submitted to unit teams in a timely manner.
( b ) The SOI or a designee may promote an inmate to a higher grade level if an opening exists when the inmate's skills, abilities, qualifications, and work performance are sufficiently developed to enable the inmate to carry out a more complex FPI factory assignment successfully, when the inmate has met the institution's time-in-grade (unless waived by the SOI), and when the inmate has abided by the inmate worker standards. Conversely, the SOI or SOI designee may demote an inmate worker for failing to abide by the inmate worker standards. Such demotions shall be fully documented.
#### § 2.203 Certificate of supervised release.

When an offender who has been released from prison to serve a term of supervised release reports to the supervision officer for the first time, the supervision officer shall deliver to the releasee a certificate listing the conditions of supervised release imposed by the Commission and shall explain the conditions to the releasee.
# C_2012331EN.01001202.xml

| 27.10.2012 | EN | Official Journal of the European Union | C 331/12 |
| --- | --- | --- | --- |

27.10.2012

EN

Official Journal of the European Union

C 331/12

---

Judgment of the Court (Sixth Chamber) of 6 September 2012 (reference for a preliminary ruling from the Hoge Raad der Nederlanden — Netherlands) — Lowlands Design Holding BV v Minister van Financiën

(Case C-524/11) (1)

(Common Customs Tariff - Combined Nomenclature - Tariff classification - Romper bags for babies and young children - Subheadings 6209 20 00 or 6211 42 90)

(2012/C 331/19)

Language of the case: Dutch

Referring court

Hoge Raad der Nederlanden

Parties to the main proceedings

Applicant: Lowlands Design Holding BV

Defendant: Minister van Financiën

Re:

Reference for a preliminary ruling — Hoge Raad der Nederlanden — Interpretation of Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff (OJ 1987 L 256, p. 1) and of Commission Regulation (EC) No 651/2007 of 8 June 2007 concerning the classification of certain goods in the Combined Nomenclature (OJ 2007 L 153, p. 3) — Sleeping bags for babies and for children

Operative part of the judgment

The Combined Nomenclature forming Annex I to Council Regulation (EEC) No 2658/87 of 23 July 1987 on the tariff and statistical nomenclature and on the Common Customs Tariff, as amended by Commission Regulation (EC) No 1719/2005 of 27 October 2005, must be interpreted as meaning that romper bags such as those at issue in the main proceedings must be classified under subheading 6209 20 00 as ‘babies’ garments and clothing accessories, of cotton’ if, on account of their size, they are suitable for young children of a body height not exceeding 86 cm. If that is not the case, those products must be classified under subheading 6211 42 90 as ‘other garments, women’s or girls’, of cotton’.

---

(1)  OJ C 25, 28.1.2011.

---
### §9581. General duties

The Under Secretary may coordinate, as consistent with law, the plans, programs, and operations of the Federal Government that affect, or may contribute to, the establishment, preservation, and strengthening of socially or economically disadvantaged business concerns.

(Pub. L. 117–58, div. K, title VI, §100601, Nov. 15, 2021, 135 Stat. 1464.)
¿Se siente enfermo?

¡Quédese en casa si está enfermo!

cdc.gov/CORONAVIRUS-ES

CS 316129-B March 26, 2020 3:37 PM

NO ENTRE si tiene:

Si no se siente bien o tiene alguno de estos síntomas,

por favor, salga del edificio y comuníquese con su 

proveedor de atención médica.

Luego, póngase en contacto con su supervisor.

FIEBRE TOS DIFICULTAD 

PARA RESPIRAR

PARE
### §195a. North St. Vrain Creek and adjacent lands

Neither the Secretary of the Interior nor any other Federal agency or officer may approve or issue any permit for, or provide any assistance for, the construction of any new dam, reservoir, or impoundment on any segment of North St. Vrain Creek or its tributaries within the boundaries of Rocky Mountain National Park or on the main stem of North St. Vrain Creek downstream to the point at which the creek crosses the elevation 6,550 feet above mean sea level. Nothing in this section shall be construed to prevent the issuance of any permit for the construction of a new water gauging station on North St. Vrain Creek at the point of its confluence with Coulson Gulch.

(Jan. 26, 1915, ch. 19, §5, as added Pub. L. 104–333, div. I, title IV, §408(a), Nov. 12, 1996, 110 Stat. 4153.)
In the United States Court of Federal Claims 

OFFICE OF SPECIAL MASTERS

* * * * * * * * * * * * * * * * * * * * * 

CHRISTINE HARRISON, * 

 * No. 15-1064V 

 Petitioner, * Special Master Christian J. Moran 

 * 

v. * Filed: December 20, 2017 

 * 

SECRETARY OF HEALTH * Stipulation; Influenza (“flu”) vaccine; 

AND HUMAN SERVICES, * demyelinating event; vasculitis; 

 * amaurosis fugax; anisocria; fatigue; 

 * weakness; tingling 

 Respondent. * 

* * * * * * * * * * * * * * * * * * * * * 

Mark Sadaka, Mark T. Sadaka, LLC, Englewood, NJ, for Petitioner; 

Ryan D. Pyles, United States Dep’t of Justice, Washington, DC, for Respondent. 

UNPUBLISHED DECISION1

 On December 15, 2017, the parties filed a joint stipulation concerning the 

petition for compensation filed by Christine Harrison on September 22, 2015. 

Petitioner alleged that the influenza (“flu”) vaccine she received on September 25, 

2012, which is contained in the Vaccine Injury Table (the “Table”), 42 C.F.R. 

§100.3(a), caused her to suffer demyelinating event, vasculitis, amaurosis fugax, 

anisocria, fatigue, weakness, tingling in her mouth, face, hand, leg, feet, and pain 

in the head, face, and legs. Petitioner further alleges that she suffered the residual 

effects of this injury for more than six months. Petitioner represents that there has 

been no prior award or settlement of a civil action for damages on her behalf as a 

result of her condition. 

 

1 The E-Government Act, 44 U.S.C. § 3501 note (2012) (Federal Management and 

Promotion of Electronic Government Services), requires that the Court post this decision on its 

website. Pursuant to Vaccine Rule 18(b), the parties have 14 days to file a motion proposing 

redaction of medical information or other information described in 42 U.S.C. § 300aa-12(d)(4). 

Any redactions ordered by the special master will appear in the document posted on the website. 
2 

Respondent denies that the vaccines either caused or significantly 

aggravated petitioner’s alleged injuries or any other injury, and denies that 

petitioner's current disabilities are the result of a vaccine-related injury. 

 Nevertheless, the parties agree to the joint stipulation, attached hereto. The 

undersigned finds said stipulation reasonable and adopts it as the decision of the 

Court in awarding damages, on the terms set forth therein. 

 

Damages awarded in that stipulation include: 

A lump sum payment of $90,000.00 in the form of a check payable to 

petitioner. This amount represents compensation for all damages that 

would be available under 42 U.S.C. § 300aa-15(a). 

 In the absence of a motion for review filed pursuant to RCFC, Appendix B, 

the clerk is directed to enter judgment in case 15-1064V according to this decision 

and the attached stipulation.2

 

 

IT IS SO ORDERED. 

 

 s/Christian J. Moran 

 Christian J. Moran 

 Special Master 

 

2 Pursuant to Vaccine Rule 11(a), the parties can expedite entry of judgment by each 

party filing a notice renouncing the right to seek review by a United States Court of Federal 

Claims judge.
## Breadcrumb

-  Home 
-  Local Assistance 
-  Export and Trade Assistance 
-  U.S. Export Assistance Centers 

## Section navigation

-  Resource Partners 
-  Export and trade assistance    -  Export Finance Managers 
  -  U.S. Export Assistance Centers 
-  Federal contracting assistance 
-  Community Navigators 
-  Regional Innovation Clusters 
-  Veterans Business Development Officers 

# U.S. Export Assistance Centers

Located in metropolitan areas throughout the country, U.S. Export Assistance Centers (USEACs) support American small businesses who want to compete globally by exporting.

##         Find your nearest USEAC      

Enter a valid 5-digit ZIP Code.
# Fourt h Court of Appeals

San Antonio, Texas

July 14, 2016

No. 04

- 16

- 004 44

- CR

EX PARTE Billy Jack GUERRA

Original Habeas Corpus Proceeding 1

ORDER

Sitting: Marialyn Barnard, Justice

Patricia O. Alvarez, Justice

Jason Pulliam, Justice

On July 11 , 2016, R elator filed a pro se petition for writ of habeas corpus. The court has

determined that it lacks jurisdiction to consider R elator’s petition. Accordingly, the petition is

DISMISSED FOR LACK O F JURISDICTION

. See T EX

. R. A PP

. P . 52.8(a). The court’s

opinion will issue at a later date.

It is so ORDERED on July 14, 2016

.

_________________________________ Patricia O. Alvarez, Justice

IN WITNESS WHEREOF, I have hereunto set my hand and affixed the seal of the said

cou rt on this 14th day of July, 2016

.

___________________________________ Keith E. Hottle , Clerk

1 This proceeding arises out of Cause No. 2016CR1777, styled The State of Texas v. Billy Jack Guerra , pending in

the 144th Judicial District Court, Bexar County, Texas, the Honorable Lorina I. Rummel presiding.
Order entered January 29, 2014

In The 

## Court of Appeals **Fifth District of Texas at Dallas** No. 05 - 13 - 00692 - CV IN THE INTEREST OF N . L.T., A CHILD On Appeal from the 256th Judicial District Court Dallas County, Texas Trial C ourt Cause No. DF 04 - 10316 - Z No. 05 - 13 - 0069 3 - CV IN THE INTEREST OF M . T., A CHILD On Appeal from the 30 2 nd Judicial District Court Dallas County, Texas Trial Court Cause No. DF 06 - 08087 - U 

### O RDER Before Justices Francis and Lang

- Miers and Chief Justice Thomas, Ret. 1 Before the Court i s appellant Sharon Thomas’ s M otion for R uling on R ecusal I ssues on A ppeal

. The motion is DENIED

.

1 The Honorable Linda Thomas, Chief Justice of the Court of Appeals for the Fifth District of Texas

– Da llas, Retired, sitting by assignment. /Linda Thomas/ LINDA THOMAS CHIEF JUSTICE, RET.
### §278g–3d. Implementation of coordinated disclosure of security vulnerabilities relating to agency information systems, including Internet of Things devices

#### (a) Agency guidelines required

Not later than 2 years after December 4, 2020, the Director of OMB, in consultation with the Secretary, shall develop and oversee the implementation of policies, principles, standards, or guidelines as may be necessary to address security vulnerabilities of information systems (including Internet of Things devices).

#### (b) Operational and technical assistance

Consistent with section 3553(b) of title 44, the Secretary, in consultation with the Director of OMB, shall provide operational and technical assistance to agencies on reporting, coordinating, publishing, and receiving information about security vulnerabilities of information systems (including Internet of Things devices).

#### (c) Consistency with guidelines from National Institute of Standards and Technology

The Secretary shall ensure that the assistance provided under subsection (b) is consistent with applicable standards and publications developed by the Director of the Institute.

#### (d) Revision of Federal Acquisition Regulation

The Federal Acquisition Regulation shall be revised as necessary to implement the provisions under this section.

(Pub. L. 116–207, §6, Dec. 4, 2020, 134 Stat. 1005.)

#### **Editorial Notes**

#### Codification

Section was enacted as part of the Internet of Things Cybersecurity Improvement Act of 2020, also known as the IoT Cybersecurity Improvement Act of 2020, and not as part of the National Institute of Standards and Technology Act which comprises this chapter.

#### **Statutory Notes and Related Subsidiaries**

#### Definitions

For definitions of terms used in this section, see section 278g–3a of this title.
### IN THE UNITED STATES COURT OF APPEALS FOR THE FIFTH CIRCUIT

No. 17

- 41029 Summary Calendar

UNITED STATES OF AMERICA,
Plaintiff

− Appellee ,

v ersus ELIPDIO JORDAN

- MALDONADO , Defendant

− Appellant

.

Appeal from the United States District Court for the Eastern District of Texas No. 4:14

- CR

- 91

- 12

Before JONES, SMITH, and COSTA, Circuit Judges. PER CURIAM: *

The attorney appointed to represent Elipdio Jordan

- Maldonado has

* Pursuant to 5 TH C IR

. R. 47.5 , the court has determined that this opinion should not be published and is not precedent except under the limited circumstances set forth in 5 TH C IR

. R. 47.5.4. United States Court of Appeals Fifth Circuit 

### FILED July 23, 2018 Lyle W. Cayce Clerk Case: 17-41029 Document: 00514566627 Page: 1 Date Filed: 07/23/2018No. 17

- 41029

2 moved for leave to withdraw and has filed a brief in accordance with Anders v. California , 386 U.S. 738 (1967), and United States v. Flores , 632 F.3d 229 (5th Cir. 2011). Jordan

- Maldonado has filed a response. The record is not suffic i

ently developed for us to make a fair evaluation of Jordan

- Maldonado ’s claims of ine ffective assistance of counsel , so we decline to consider the m wi th out pre

judice to collateral review. See United States v. Isgar , 739 F.3d 829, 841 (5th Cir. 2014 )

. We have reviewed counsel’s brief , relevant portions of the record , and Jordan

- Maldonado ’s response. We concur with counsel’s assessment that the appeal presents no nonfrivolo us issue for appellate review. Accordingly, the motion for leave to withdraw is GRANTED, and counsel is excused from fur

ther responsibilities herein

. Our review does, however, reveal a clerical error in the judgment , which states that Jordan

- Maldonado pleaded guilty of conspiracy to possess with intent to manufacture and distribute cocaine. Instead, the record reflects that Jordan

- Maldonado pleaded guilty of conspiracy to possess with intent to dis

trib ute cocaine; therefore, th e word “manufacture” must be deleted from the description of the offense. The remaining question is whether we should remand. Although we could do so, courts of appellate jurisdiction are permitted to “ affirm, modify, vacate, set aside or reverse any judg ment, decree, or order of a court lawfully brought before it for review .” 28 U.S.C. § 2106. See, e.g. , United States v. Godoy , 890 F.3d 531, 542 (5th Cir. 2018); No. 15

- 41034, United States v. Cabrera , 2018 U.S. App. LEXIS 18470, at *3 (5th Cir. July 6, 2018) (per cur

iam) (unpublished). Accordingly, the judgment is AFFIRMED as MODIFIED to reflect that Jordan

- Maldonado was convicted of, and sentenced for, conspire

acy to possess with intent to distribute cocaine. Case: 17-41029 Document: 00514566627 Page: 2 Date Filed: 07/23/2018
#### Cosmopolitan National Bank, Plaintiff-Appellee, *v.*City of Chicago, Defendant-Appellant.

(No. 54464;

First District

August 31, 1971.

Richard L. Curry, of Chicago, (Marvin E. Aspen and Howard C. Goldman, of counsel,) for appellant.

Opinion by

Mr. PRESIDING JUSTICE LEIGHTON.
### §159c. Completion of establishment

For the purpose of completing the establishment of Saratoga National Historical Park, and to provide adequately for its future development, all lands and other property which have been acquired by the Federal Government pursuant to sections 159 to 159b of this title are established as the Saratoga National Historical Park and shall be administered as provided in section 159b of this title.

(June 22, 1948, ch. 594, §1, 62 Stat. 570.)
What Your Test Results Mean

If you test positive for COVID-19

TAKE STEPS TO HELP PREVENT THE SPREAD OF COVID-19

STAY HOME. 

Do not leave your home, 

except to get medical care. Do 

not visit public areas.

GET REST AND STAY HYDRATED. 

Take over-the-counter medicines, 

such as acetaminophen, to help 

you feel better.

If you test negative for COVID-19

• You probably were not infected at the time your sample 

was collected. 

• However, that does not mean you will not get sick. 

• It is possible that you were very early in your infection when your 

sample was collected and that you could test positive later. 

317369-A | May 30, 2020 7:25 PM

Accessible version available at https://www.cdc.gov/coronavirus/2019-ncov/testing/diagnostic-testing.html 

STAY IN TOUCH WITH 

YOUR DOCTOR. 

SEPARATE YOURSELF FROM 

OTHER PEOPLE.

As much as possible, stay in a specific 

room and away from other people 

and pets in your home.

A negative test 

result does not

mean you won’t 

get sick later.

CDC.GOV/CORONAVIRUS
Exhibit
32.2





CERTIFICATION
PURSUANT


TO
18 U.S.C. SECTION 1350,


AS
ADOPTED PURSUANT TO


SECTION 
906 OF THE SARBANES-OXLEY ACT OF 2002





The
undersigned Chief Financial Officer, Senior Vice President, Finance and
Operations and Treasurer of Progenics Pharmaceuticals, Inc. (the “Company”) does
hereby certify as follows:





This
annual report on Form 10-K of the Company for the period ended December 31,
2008 and filed with the Securities and Exchange Commission on the date hereof
(the “Report”) fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934 and the information contained in
the Report fairly presents, in all material respects, the financial condition
and results of operations of the Company.





/s/
      Robert A. McKinneyDate:
      March 13, 2009
            Robert
      A. McKinney
              Chief
      Financial Officer, Senior Vice President, Finance & Operations and
      Treasurer (Principal Financial
Officer)








A signed
original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears
in typed form within the electronic version of this written statement required
by Section 906, has been provided to Progenics Pharmaceuticals, Inc. and
will be retained by Progenics Pharmaceuticals, Inc. and furnished to the
Securities and Exchange Commission or its staff upon
request